Laura E Niklason

Hillsborough, NC, United States of America

Laura E Niklason

This inventor holds 31 USPTO granted patents and 16 published patent applications, plus 15 CIPO patents and 15 EPO patents, primarily in Tissue Engineering. Top assignees: Yale University, Humacyte, Inc, Duke University. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura E Niklason. Retrieved from https://idiyas.com/inventor/laura-e-niklason

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 93.5


 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 273(Granted Patents)


Location History:

  • Hillsborough, NC (US) (2002 - 2011)
  • New Haven, CT (US) (2018)
  • Greenwich, NC (US) (2019)
  • Durham, NC (US) (2021)
  • Greenwich, CT (US) (2011 - 2024)

Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Airway Cells
Tubular Prostheses
Tissue Constructs
Bioreactor
Epithelial Cell Differentiation
Anti-Thrombogenic Grafts
Human iPS Cells
Soft Tissue Augmentation
Decellularized Tissue
Cerebral Vasospasm
Electrospinning
Cultivating Tissue
31 patents (USPTO):Explore Patents

Title: Laura E Niklason: Innovator in Biomedical Engineering

Introduction

Laura E Niklason, based in Hillsborough, NC, is a prominent inventor in the field of biomedical engineering. With an impressive portfolio of 26 patents, she has made remarkable contributions to medical technology, particularly in the areas of diabetes treatment and respiratory health.

Latest Patents

Laura's latest patents include groundbreaking innovations. One notable invention is the "Bioartificial Vascular Pancreas," which offers compositions, systems, and methods to treat diabetes. This invention features a decellularized vascular graft combined with a biocompatible hydrogel encasement and pancreatic islet cells, showcasing a novel approach to managing diabetes.

Additionally, Laura has developed compositions and methods for preparing airway cells, emphasizing the differentiation of induced pluripotent stem (iPS) cells into epithelial airway cells. Her work on engineered lungs aims to address respiratory disorders through the application of these specialized cells.

Career Highlights

Throughout her career, Laura has been affiliated with renowned institutions such as Yale University and Humacyte, Inc. Her tenure at these organizations has provided her with the platform to advance her research and innovation in the biomedical field.

Collaborations

Laura has collaborated with esteemed colleagues, including Justin T Strader and William E Tente. These partnerships have further enriched her projects and contributed to the development of transformative medical solutions.

Conclusion

With her innovative spirit and technical expertise, Laura E Niklason continues to shape the future of healthcare. Her patents stand as a testament to her dedication to improving patient outcomes and addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…